Advancement in product development, accelerated market entry and exhibitions: In 2024, Uniogen experienced an exceptional year marked by significant progress and innovations in research and development in the areas of oncology and new system development. Our R&D teams pushed boundaries, resulting in groundbreaking solutions that can be expected to set… Read More
Wishing you a joyous holiday season and a prosperous New Year filled with success and new opportunities! To recharge and celebrate the season, our team will be taking a short break over the holidays. While we’ll still be here to assist you, we will have fewer people in the office… Read More
Lumito has developed a ground-breaking histopathological tissue analysis solution called SCIZYS. The detection of the tissue samples is partly based on UpconTM nanoparticle technology provided by Uniogen. The technology is based on upconverting nanoparticles enabling autofluorescence free measurement. Combined with traditional brightfield imaging, it produces images… Read More
In August the company was accepted into the AMPlify program (an accelerated market entry platform), which is organized in collaboration with Mayo Clinic (USA) and Business Finland. The program supports the commercialization projects of the company’s ovarian cancer test currently under development. Our… Read More
Kaisa Huhtinen, Uniogen´s Oncology Clinical Manager, has a deep understanding of ovarian cancer diagnostics as a PhD and an Associate Professor. Kaisa is participating in the European Society of Medical Oncology (ESMO)– congress held in Barcelona the 13th – 17… Read More
Uniogen’s commitment to environmental, social, and governance (ESG) principles has never been stronger, as demonstrated in our 2023 Sustainability report. We caught up with Maija Jortikka, our Sustainability Specialist, to discuss this year’s highlights and the impactful changes Uniogen is implementing. Embracing a robust Code of Conduct Maija begins… Read More
April was an exciting month for Uniogen, filled with significant participation at three major global congresses that align closely with our mission and expertise. We are thrilled to share key insights and developments from these events, reinforcing our commitment to innovation and collaboration in the fields of clinical diagnostics… Read More
Upcon™ upconverting nanoparticle (UCNP) system is breaking new ground in the world of diagnostics. This advanced detection technology utilizes photon upconversion to enhance lateral flow assays, making it a game-changer for diagnostic accuracy and performance. Why choose Upcon? The Upcon system is not just another diagnostic tool—it’s a comprehensive solution… Read More
Uniogen has been featured in Finland’s national public broadcasting company news for developing… Read More
As spring blooms, Uniogen is gearing up for a dynamic April, packed with participation in three significant events: UPCON 2024 in Montréal, Analytica 2024 in Munich, and ECCMID 2024 in Barcelona. First, we are excited to attend the UPCON 2024 conference with our own booth, starting on April 7… Read More
